These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23774740)

  • 1. Thymoglobulin and its use in renal transplantation: a review.
    Thiyagarajan UM; Ponnuswamy A; Bagul A
    Am J Nephrol; 2013; 37(6):586-601. PubMed ID: 23774740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
    Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
    Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single center experience with thymoglobulin in renal transplantation.
    Zaltzman JS; Paul LC
    Transplant Proc; 1997 Nov; 29(7A):27S-28S. PubMed ID: 9366924
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function.
    Chen G; Gu J; Qiu J; Wang C; Fei J; Deng S; Li J; Huang G; Fu Q; Chen L
    Exp Clin Transplant; 2013 Aug; 11(4):310-4. PubMed ID: 23121641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients.
    Carter JT; Melcher ML; Carlson LL; Roland ME; Stock PG
    Am J Transplant; 2006 Apr; 6(4):753-60. PubMed ID: 16539632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation.
    Tchervenkov J; Flemming C; Guttmann RD; des Gachons G
    Transplant Proc; 1997 Nov; 29(7A):13S-15S. PubMed ID: 9366919
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results.
    Hardinger KL; Rhee S; Buchanan P; Koch M; Miller B; Enkvetchakul D; Schuessler R; Schnitzler MA; Brennan DC
    Transplantation; 2008 Oct; 86(7):947-52. PubMed ID: 18852661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
    Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
    Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-center experience in pediatric renal transplantation using thymoglobulin induction and steroid minimization.
    Warejko JK; Hmiel SP
    Pediatr Transplant; 2014 Dec; 18(8):816-21. PubMed ID: 25311592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
    Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
    Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation.
    Mehrabi A; Mood ZhA; Sadeghi M; Schmied BM; Müller SA; Welsch T; Kuttymuratov G; Wente MN; Weitz J; Zeier M; Morath Ch; Riediger C; Schemmer P; Encke J; Büchler MW; Schmidt J
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii54-viii60. PubMed ID: 17890265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
    Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
    Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sequential protocols with thymoglobuline and delayed introduction of calcineurin: effects on renal function in renal transplant recipients with non immunological risk and low risk of delayed graft function].
    Ricard-Sutra E; Garrigue V; Bismuth J; Chong G; Argiles A; Mourad G
    Nephrologie; 2004; 25(4):127-32. PubMed ID: 15291140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study.
    Cicora F; Mos F; Paz M; Roberti J
    Exp Clin Transplant; 2013 Oct; 11(5):418-22. PubMed ID: 23909577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction with basiliximab plus thymoglobulin is effective and safe in old-for-old renal transplantation: six-month results of a prospective clinical study.
    Favi E; Gargiulo A; Spagnoletti G; Salerno MP; Silvestrini N; Valente I; Citterio F
    Transplant Proc; 2010 May; 42(4):1114-7. PubMed ID: 20534237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Thymoglobulin® (antithymocyte immunoglobulin) in renal transplantation: practical guide.
    de Castro MC; Deboni L; Esmeraldo Rde M; Matuk TA; Pacheco A; Saitovitch D; Salomão A; Silva Junior HT; Villaça S
    J Bras Nefrol; 2015; 37(2):228-40. PubMed ID: 26154644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
    Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.